Cambridge Healthtech Institute Announces its PCR Part I: qPCR in Molecular Diagnostics Short Course

CHI's PCR Part I: qPCR in Molecular Diagnostics Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.
Spread the Word
Listed Under

* Cambridge Healthtech Institute
* Life Science
* Diagnostics
* Pcr
* Technology

* Biotech
* Science

* Needham - Massachusetts - US

* Features

Jan. 4, 2013 - PRLog -- NEEDHAM, MASS. – Cambridge Healthtech Institute releases full details for its PCR Part I: qPCR in Molecular Diagnostics Short Course, which will take place on February 12, 2013 from 1:30-4:30 P.M. at the Moscone North Convention Center in San Francisco, CA.  This course will cover aspects of incorporating qPCR into standard diagnosis including the challenges involved, an overview of the technology available, and next steps.

Course Instructors Include:

• Fred Russell Kramer, Ph.D., Professor, Department of Microbiology and Molecular Genetics, Public Health Research Institute, New Jersey Medical School
• Steve Miller, M.D., Ph.D., Director, UCSF Clinical Microbiology Laboratory
• G. Mike Makrigiorgos, Ph.D., Director, Biophysics Laboratory and Medical Physics Division, Dana Farber Cancer Institute, Harvard Medical School


• Review and Recent Developments in qRT-PCR Signal Generation and in Mutation-Specific qRT-PCR Signal Generation
• Overview of CMV PCR Testing: Validating and Implementing a Laboratory-Validated Test
• The Principles of Designing Molecular Beacon Probes for PCR Assays

Advance registration discounts are available until January 11, 2013. To view a detailed short course agenda and to register, please visit

To inquire about sponsoring and/or exhibiting, contact Jon Stroup (781-972-5483 or or Joseph Vacca (781-972-5431 or

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at

About Cambridge Healthtech Institute (

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and Cambridge Healthtech Media Group.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Molecular Med Tri-Conference 2013 (

The 20th International Molecular Med Tri-Conference is the leading drug discovery research event covering a broad spectrum of cutting-edge topics within molecular medicine with scientific, business and regulatory viewpoints. Join over 3,000 of your colleagues in interactive lectures, discussions, and various networking receptions to hear differing views and perspectives on poignant issues facing you and our industry today. Spanning five days, the Tri-Conference includes 5 Concurrent Symposia, the Emerging Molecular Diagnostics Partnering Forum, 15 Afternoon & Dinner Short Courses and 15 Conference Programs.

Laura Norton
Cambridge Healthtech Institute
Email:*** Email Verified
Tags:Cambridge Healthtech Institute, Life Science, Diagnostics, Pcr, Technology
Industry:Biotech, Science
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Daily News
Weekly News

Like PRLog?
Click to Share